Number of the records: 1
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer
- Phase II study of avelumab in multiple relapsed/refractory germ cell cancer / Mego M. ... [et al.]. Onkológia Roč. 14, č. 3 (2019), s. 216
article
Number of the records: 1